|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 1/18 | |
| A61K 38/37 | |||
| C12P 21/04 | |||
| C12P 21/06 | |||
| C12N 5/07 | |||
| C12N 5/14 | |||
| C07K 1/36 | |||
| C07K 1/22 | |||
| C07K 14/755 |
| (11) | Number of the document | 3043813 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14834927.7 |
| Date of filing the European patent application | 2014-08-08 | |
| (97) | Date of publication of the European application | 2016-07-20 |
| (45) | Date of publication and mention of the grant of the patent | 2021-01-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/050411 |
| Date | 2014-08-08 |
| (87) | Number | WO 2015/021423 |
| Date | 2015-02-12 |
| (30) | Number | Date | Country code |
| 201361863810 P | 2013-08-08 | US |
| (72) |
ZHU, Lily, US
KOLE, Anxhela, US
KULMAN, John, US
ACOSTA, Marisol, US
|
| (73) |
Bioverativ Therapeutics Inc.,
225 Second Avenue, Waltham, MA 02451,
US
|
| (54) | PURIFICATION OF CHIMERIC FVIII MOLECULES |
| PURIFICATION OF CHIMERIC FVIII MOLECULES |